Jefferies Downgrades XOMA, Ltd. (XOMA) to Hold
Get Alerts XOMA Hot Sheet
Rating Summary:
4 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Join SI Premium – FREE
Jefferies downgraded XOMA, Ltd. (NASDAQ: XOMA) from Buy to Hold with a price target of $1.00 (from $7.00).
Analyst Biren Amin commented, "XOMA announced that gevokizumab missed on the primary endpoint on time to first exacerbation in EYEGUARD-B for Behcet’s uveitis as a result of placebo having performed better than expected. It appears part of the reason for the placebo response may be due to the administration of a minimum effective dose of steroids in the placebo group. As a result, we have removed all gevo revenues for NIU in our model and are downgrading to a Hold with $1 PT."
For an analyst ratings summary and ratings history on XOMA, Ltd. click here. For more ratings news on XOMA, Ltd. click here.
Shares of XOMA, Ltd. closed at $1.00 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Keurig Dr Pepper (KDP) PT Raised to $39 at Jefferies
- FANUC Corp (6954:JP) (FANUY) PT Raised to JPY5,300 at Nomura/Instinet
- MarineMax (HZO) PT Lowered to $35 at Stifel
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT Change, DowngradesRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!